Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNS Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT05116618
What this trial is testing

Detection of Resistance Mechanisms in Cerebrospinal Fluid for EGFR-mutant, ALK- and ROS1-rearranged

Who this might be right for
Non-Small Cell Lung Cancer
University of Colorado, Denver
Not applicableStudy completedNCT00005459
What this trial is testing

Risk of Coronary Heart Disease in Women With Polycystic Ovary Syndrome

Who this might be right for
AtherosclerosisCardiovascular DiseasesHeart Diseases+3 more
National Heart, Lung, and Blood Institute (NHLBI)
Early research (Phase 1)Study completedNCT01222780
What this trial is testing

To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer

Who this might be right for
SarcomaNeuroblastomaWilms Tumor+3 more
Acrotech Biopharma Inc. 22
Testing effectiveness (Phase 2)Looking for participantsNCT07336446
What this trial is testing

A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs

Who this might be right for
Prostate Cancer
AstraZeneca 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07343479
What this trial is testing

Sacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain Metastases

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)EGFR Gene MutationsBrain Metastasis
Zhejiang Cancer Hospital 45
Not applicableStudy completedNCT00285324
What this trial is testing

Diffusion Tensor MRI to Distinguish Brain Tumor Recurrence From Radiation Necrosis

Who this might be right for
Glioma Tumor RecurrenceRadiation NecrosisPrimary Brain Tumor
National Institute of Neurological Disorders and Stroke (NINDS) 29
Early research (Phase 1)WithdrawnNCT01130623
What this trial is testing

A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors

Who this might be right for
SarcomaNeuroblastomaWilms Tumor+2 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT02303678
What this trial is testing

D2C7 for Adult Patients With Recurrent Malignant Glioma

Who this might be right for
Malignant GliomaBrain Tumor, Recurrent
Darell Bigner 81
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT00074191
What this trial is testing

Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma

Who this might be right for
Lymphoma
OHSU Knight Cancer Institute 1
Not applicableLooking for participantsNCT05370079
What this trial is testing

Control Cohort CTRL COH

Who this might be right for
Parkinson's Disease; Amyotrophic Lateral Sclerosis; Glioblastoma; Cancer Without Neurological Disease; Rheumatoid Polyarthritis
Hospices Civils de Lyon 350
Post-approval studies (Phase 4)UnknownNCT04399343
What this trial is testing

Dexmedetomidine for Prevention of Postoperative Delirium After Intracranial Operation for Brain Tumor

Who this might be right for
Central Nervous System Diseases
Capital Medical University 700
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07681297
What this trial is testing

Tislelizumab in Combination With Bevacizumab and Capecitabine in Advanced Solid Tumors With Evaluation in Immunotherapy-Resistant and Central Nervous System Disease

Who this might be right for
Advanced Solid Tumor CancerTriple-Negative Breast Cancer (TNBC)CNS Disease+1 more
National University Hospital, Singapore 154
Testing effectiveness (Phase 2)Study completedNCT00058123
What this trial is testing

Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 55
Testing effectiveness (Phase 2)Ended earlyNCT00074334
What this trial is testing

TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium 3
Not applicableStudy completedNCT00004875
What this trial is testing

Heparin or Enoxaparin in Patients With Cancer

Who this might be right for
LymphomaThromboembolismUnspecified Adult Solid Tumor, Protocol Specific
Northwestern University 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Post-approval studies (Phase 4)Active Not RecruitingNCT05044819
What this trial is testing

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

Who this might be right for
Lennox Gastaut SyndromeDravet SyndromeTuberous Sclerosis Complex
Jazz Pharmaceuticals 154
Testing effectiveness (Phase 2)Study completedNCT03566199
What this trial is testing

MTX110 by Convection-Enhanced Delivery in Treating Participants With Newly-Diagnosed Diffuse Intrinsic Pontine Glioma

Who this might be right for
Diffuse Intrinsic Pontine Glioma
Sabine Mueller, MD, PhD 7
Testing effectiveness (Phase 2)Study completedNCT00086879
What this trial is testing

Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 110
Next Page